GW003

BIOLOGICAL3 trials

Sponsors

Jiangsu T-Mab Biopharma Co.,Ltd

Conditions

Chemotherapy-induced NeutropeniaMetastatic Tumors

Phase 1

Safety and Pharmacokinetic(PK) Study of GW003 to Metastatic Tumors

CompletedNCT02156388

Jiangsu T-Mab Biopharma Co.,LtdChemotherapy-induced Neutropenia, Metastatic Tumors

Start: 2013-08-31End: 2015-12-31Updated: 2016-02-24

Tolerability and Pharmacokinetics(PK)/Pharmacodynamics(PD) Study of GW003 in Healthy Subjects

CompletedNCT02643901

Jiangsu T-Mab Biopharma Co.,LtdChemotherapy-induced Neutropenia

Start: 2015-09-30End: 2016-10-10Updated: 2017-08-18

Study to Assess the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of GW003 in Patients With Breast Cancer

Jiangsu T-Mab Biopharma Co.,LtdChemotherapy-induced Neutropenia

Start: 2016-03-31End: 2017-09-30Target: 30Updated: 2017-08-18